Zhen Health
AI-powered fundus imaging technology for ophthalmology diagnostics
About Zhen Health
Founded in 2015, Zhen Health (Beijing Zhizhen Internet Technology Co., Ltd.) is a medical technology company specializing in digital healthcare management and services for eye health. The company leverages artificial intelligence, clinical big data, and cloud computing to enhance the efficiency of primary care services. Zhen Health's core offering is a fundus imaging camera combined with AI-driven algorithms designed to assist doctors in making faster and more accurate diagnoses of various eye disorders. The technology has broad applications across multiple medical departments, including ophthalmology, endocrinology, neurology, and pediatrics.
The company provides solutions for the early screening of eye conditions related to widespread chronic diseases. This includes screenings for diabetic retinopathy, hypertensive retinopathy, and potential indicators of conditions like glaucoma, stroke, and Alzheimer's disease visible in the fundus. By connecting patients, medical institutions, and ophthalmology experts, Zhen Health aims to implement a hierarchical diagnosis and treatment model, creating an integrated online and offline intelligent eye health management platform. Its business model is described as B2B2P (Business-to-Business-to-Patient).
Zhen Health is a privately held, venture capital-backed company headquartered in Beijing, China. It has successfully raised a total of $25.17 million, with a significant funding round of $15.7 million in January 2022. Key investors include Baidu Ventures, GP Capital, HuaXia HengTian, Xiran Capital, and Horus Capital.
Source: Dealroom company dataNews
Open roles
Zhen Health in the Haidian ecosystem
The Zhen Health office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
- GCGP Capital
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Zhen Health on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Zhen Health on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.